| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/15/2003 | US6548641 PTP 1D: a novel protein tyrosine phosphatase |
| 04/15/2003 | US6548639 IgG-binding protein from Staphylococcus and nucleotide sequence encoding this protein |
| 04/15/2003 | US6548636 Composition for use as viricide in prevention of viral infection |
| 04/15/2003 | US6548635 Protein or polypeptide that binds with an antibody that binds to a polypeptide of the specific amino acid sequence; for diagnosis and the preparation of vaccines |
| 04/15/2003 | US6548634 Peptidic composition linked to an oligomerization domain directly or through a linker or heparin binding domain; no homology to naturally occuring fibroblast growth factors (fgf) |
| 04/15/2003 | US6548633 Complementary DNA's encoding proteins with signal peptides |
| 04/15/2003 | US6548632 Fusions of scaffold proteins with random peptide libraries |
| 04/15/2003 | US6548631 Macrophage derived chemokine (MDC) as an anti-viral agent for the treatment and prevention of lentivirus infection |
| 04/15/2003 | US6548630 Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
| 04/15/2003 | US6548482 Treatment of osteoporosis |
| 04/15/2003 | US6548477 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 04/15/2003 | US6548475 Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuronal and neural injury |
| 04/15/2003 | US6548306 Placental protein 13 |
| 04/15/2003 | US6548296 Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereof |
| 04/15/2003 | US6548292 From Pseudomonas; comprises genes encoding enzymes involved in catchol cleavage, mercury tolerance, plasmid stability, and replication |
| 04/15/2003 | US6548291 Polynucleotide sequences/transgenic cells of Bacillus thuringiensis |
| 04/15/2003 | US6548290 Geminin gene and protein |
| 04/15/2003 | US6548289 Integrating into a symbiotically silent region of Rhizobium meliloti DNA encoding for inositol dehydrogenase (IDH), a cassette comprising transcriptional promoter gene |
| 04/15/2003 | US6548286 Methods for increasing the efficiency of recombinant AAV product |
| 04/15/2003 | US6548281 Polypeptides, polynucleotides formed via recombination; for screening for antibacterial compounds |
| 04/15/2003 | US6548280 Genes encoding sulfate assimilation proteins |
| 04/15/2003 | US6548279 For polypeptides able to catalyze the enzymatic function of superoxide dismutase, carbonic anhydrase, or HIV protease |
| 04/15/2003 | US6548273 lacR from Streptococcus pneumoniae |
| 04/15/2003 | US6548272 Pathogenic gene for bipolar affective disorder |
| 04/15/2003 | US6548271 Introducing into a cell an expression vector containing nucleic acid molecule operatively associated with regulatory nucleic acid controlling expression of nucleic acid molecule in the cell; culturing the cell to produce polypeptide |
| 04/15/2003 | US6548270 An expression vector comprising a recombinant polynucleotide encoding a protein containing specific amino acid sequence; genetic engineering |
| 04/15/2003 | US6548269 A nucleotides that encode obesity receptor (ObR), a receptor protein that participates in mammalian body weight regualation; genetic engineering |
| 04/15/2003 | US6548262 Hemostasis system-related disorders treatment |
| 04/15/2003 | US6548258 Methods for diagnosing tuberous sclerosis by detecting mutation in the TSC-1 gene |
| 04/15/2003 | US6548249 Fusions of scaffold proteins with random peptide libraries |
| 04/15/2003 | US6548077 Purifying type I collagen using two papain treatments and reducing and delipidation agents |
| 04/15/2003 | US6548070 Attenuated strains of mycobacteria |
| 04/15/2003 | US6548068 Genetic engineered vaccine; gene coding antigen to disease and genetic engineerded viruses inserted into genome |
| 04/15/2003 | US6548067 Antigenic constructs of major histocompatibility complex class I antigens with specific carrier molecules, the preparation and use thereof |
| 04/15/2003 | US6548066 Inducing antibodies; antitumor agent |
| 04/15/2003 | US6548065 Interleukin-15 receptors |
| 04/15/2003 | US6548064 Polypeptide |
| 04/15/2003 | US6548063 Synferon |
| 04/15/2003 | US6548060 Anti-apoptotic use of human glutaminyl-tRNA synthetase with two consecutive pro-apoptotic mediators |
| 04/15/2003 | US6548056 Autoimmune disease; anticancer agents |
| 04/15/2003 | CA2348665C Root-preferred promoters and their use |
| 04/15/2003 | CA2245594C Bioluminescent novelty items |
| 04/15/2003 | CA2059979C Complex containing coagulation factor ix |
| 04/15/2003 | CA2034504C Fungal stress proteins |
| 04/11/2003 | WO2002030961A1 Novel peptides |
| 04/11/2003 | CA2425769A1 Novel peptides |
| 04/10/2003 | WO2003029824A1 Method and agent for diagnosing and treating chronic inflammatory bowel diseases |
| 04/10/2003 | WO2003029778A2 Novel secreted proteins and their uses |
| 04/10/2003 | WO2003029488A2 A method for the early detection of cancer |
| 04/10/2003 | WO2003029484A2 Antimicrobial methods and materials |
| 04/10/2003 | WO2003029482A2 Diagnosing, treating, and preventing cancer using cables |
| 04/10/2003 | WO2003029475A1 MAMMALIAN CELL-INFECTING VIRUS VECTOR ENCODING EPITOPE-BOUND β2m AND UTILIZATION THEREOF |
| 04/10/2003 | WO2003029471A1 Muteins of apolipoprotein d |
| 04/10/2003 | WO2003029469A1 Novel selenocystein-containing proteins |
| 04/10/2003 | WO2003029468A1 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 04/10/2003 | WO2003029467A1 Candidate protein for novel cell polarization factor and polynucleotide encoding the protein |
| 04/10/2003 | WO2003029466A1 Sodium-independent transporter transporting small-sized neutral amino acid, gene thereof and method of analyzing transporter function by constructing fused proteins enabling the specification of the function |
| 04/10/2003 | WO2003029465A1 HepNaDC GENE |
| 04/10/2003 | WO2003029464A2 Genes associated with mast cell activation |
| 04/10/2003 | WO2003029463A2 Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| 04/10/2003 | WO2003029462A1 Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| 04/10/2003 | WO2003029461A1 A method of genetic screening using an amplifiable gene |
| 04/10/2003 | WO2003029460A1 Polynucleotide fragments of an infectious human endogenous retrovirus |
| 04/10/2003 | WO2003029454A2 Non-human animal model for analysis of the origin and therapy of organ fibrosis |
| 04/10/2003 | WO2003029442A1 Method for production of recombinant proteins in eukaryote cells |
| 04/10/2003 | WO2003029437A2 Secreted proteins |
| 04/10/2003 | WO2003029436A2 Ul16 binding protein 4 |
| 04/10/2003 | WO2003029428A2 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease |
| 04/10/2003 | WO2003029426A2 Human and murine cytokine polypeptides |
| 04/10/2003 | WO2003029424A2 Novel proteins and nucleic acids encoding same |
| 04/10/2003 | WO2003029423A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/10/2003 | WO2003029420A2 Apo-2 ligand variants and uses thereof |
| 04/10/2003 | WO2003029419A2 Three dimensional structure of crystalline grp94 binding domain, and its methods of use |
| 04/10/2003 | WO2003029416A2 Recombinant respiratory syncytial viruses with deleted surface glycoprotein genes and uses thereof |
| 04/10/2003 | WO2003029414A2 INTRODUCTION OF THE WLDs GENE FOR PREVENTION OF AXONAL DEGENERATION IN NEUROLOGICAL DISEASES |
| 04/10/2003 | WO2003029413A2 A novel g protein-coupled receptor, gave 10 |
| 04/10/2003 | WO2003029408A2 Esr2 - a plant gene that can promote plant regeneration and transformation |
| 04/10/2003 | WO2003029407A2 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 04/10/2003 | WO2003029405A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 04/10/2003 | WO2003029404A2 MAST CELL RasGRP4 COMPOSITIONS AND RELATED METHODS |
| 04/10/2003 | WO2003029401A2 Peptidoglycan recognition protein encoding nucleic acids and methods of use thereof |
| 04/10/2003 | WO2003029399A2 Regulatory sequence for the specific expression in fruit of a gene and the applications thereof |
| 04/10/2003 | WO2003029293A2 Modulators of notch ic protease activity for use in immunotherapy |
| 04/10/2003 | WO2003029292A2 Gene regulatory peptides |
| 04/10/2003 | WO2003029291A2 Pegylated and diglycosylated erythropoietin |
| 04/10/2003 | WO2003029290A1 Drug transporter and use thereof |
| 04/10/2003 | WO2003029289A2 Fragements of heat shock proteins and their use |
| 04/10/2003 | WO2003029288A2 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same |
| 04/10/2003 | WO2003029287A1 Ferroportin-1 mutant |
| 04/10/2003 | WO2003029286A1 Fluorescent proteins |
| 04/10/2003 | WO2003029285A2 Identification of cd8 epitopes from hiv-1 proteins for prevention and therapy of hiv infections |
| 04/10/2003 | WO2003029284A1 Anti-hiv agent |
| 04/10/2003 | WO2003029283A2 Genetic sequences related to bone diseases in the osteopetrotic grey-lethal (gl) mouse |
| 04/10/2003 | WO2003029282A2 Tumor-peptide antigens from the human prdi-bf1-protein |
| 04/10/2003 | WO2003029280A2 Grb7: novel regulator of lymphocyte signaling |
| 04/10/2003 | WO2003029279A2 Immunodominant acetylcholine receptor alpha subunit peptide: mhc complexes |
| 04/10/2003 | WO2003029276A2 Copolymers for suppression of autoimmune diseases, and methods of use |
| 04/10/2003 | WO2003029275A2 Anti-angiogenic peptides |
| 04/10/2003 | WO2003029274A2 Paramyxoviruses as gene transfer vectors to lung cells |
| 04/10/2003 | WO2003029271A2 Novel nucleic acids and polypeptides |